Q2 2026 saw sales rise to $2.2B and adjusted EBITDA reach $269M, with strong segment growth and robust backlog. Full-year EPS guidance was raised to $4.70–$5.10, supported by improved free cash flow and continued demand, despite margin pressures from tariffs and integration costs.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.